Merck KGaA (MKKGY) Projected to Post Earnings on Thursday

Merck KGaA (OTCMKTS:MKKGY) is projected to post its results before the market opens on Thursday, November 12th. Analysts expect Merck KGaA to announce earnings of $0.50 per share and revenue of $6.12 billion for the quarter.

Merck KGaA Stock Performance

Shares of MKKGY stock opened at $33.78 on Tuesday. The company has a quick ratio of 1.09, a current ratio of 1.69 and a debt-to-equity ratio of 0.37. Merck KGaA has a 52 week low of $23.73 and a 52 week high of $34.19. The stock has a market capitalization of $21.83 billion, a PE ratio of 17.41, a P/E/G ratio of 2.96 and a beta of 0.92. The firm has a 50 day moving average of $31.65 and a two-hundred day moving average of $30.03.

Wall Street Analysts Forecast Growth

MKKGY has been the topic of a number of recent research reports. Zacks Research lowered Merck KGaA from a “hold” rating to a “strong sell” rating in a research report on Monday, October 12th. UBS Group lowered Merck KGaA from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 20th. Five analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Reduce”.

About Merck KGaA

Merck KGaA is a German science and technology company headquartered in Darmstadt. Founded in 1668, it traces its origins to a pharmacy established by the Merck family and has grown into a global business serving customers in healthcare, research and industry. It is separate from the U.S.-based Merck & Co

The company operates through three main businesses. Its Healthcare division develops and markets prescription medicines, including treatments in areas such as oncology, neurology and fertility.